(Q46920544)

26 December 2017

title

Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect (English)

1 reference

26 December 2017

0 references

0 references

1 reference

Mustafa Büyükavci

1

1 reference

26 December 2017

Oner Ozdemir

2

1 reference

26 December 2017

Steven Buck

3

1 reference

26 December 2017

Mark Stout

4

1 reference

26 December 2017

Yaddanapudi Ravindranath

5

1 reference

26 December 2017

Süreyya Savaşan

6

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

Fundamental and Clinical Pharmacology

published in

1 reference

26 December 2017

volume

20

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

73-79

1 reference

26 December 2017

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

1 reference

Melatonin and cell death: differential actions on apoptosis in normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Melatonin: reducing the toxicity and increasing the efficacy of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Potential protective effects of melatonin on bone marrow of rats exposed to cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Cell‐mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinV/propidium iodide colabeling by fluorosphere‐adjusted counts on three‐color flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Flow cytometric measurement of lipid peroxidation in vital cells using parinaric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Circadian rhythms, oxidative stress, and antioxidative defense mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Protective effect of melatonin against adriamycin toxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00389.X

10.1111/J.1472-8206.2005.00389.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017